Suppr超能文献

低级别导管原位癌的诊断挑战

The diagnostic challenge of low-grade ductal carcinoma in situ.

作者信息

Onega Tracy, Weaver Donald L, Frederick Paul D, Allison Kimberly H, Tosteson Anna N A, Carney Patricia A, Geller Berta M, Longton Gary M, Nelson Heidi D, Oster Natalia V, Pepe Margaret S, Elmore Joann G

机构信息

Department of Biomedical Data Science, Department of Epidemiology, The Dartmouth Institute for Health Policy and Clinical Practice and Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.

Department of Pathology, University of Vermont and UVM Cancer Center, Burlington, VT, USA.

出版信息

Eur J Cancer. 2017 Jul;80:39-47. doi: 10.1016/j.ejca.2017.04.013. Epub 2017 May 20.

Abstract

BACKGROUND

Diagnostic agreement among pathologists is 84% for ductal carcinoma in situ (DCIS). Studies of interpretive variation according to grade are limited.

METHODS

A national sample of 115 pathologists interpreted 240 breast pathology test set cases in the Breast Pathology Study and their interpretations were compared to expert consensus interpretations. We assessed agreement of pathologists' interpretations with a consensus reference diagnosis of DCIS dichotomised into low- and high-grade lesions. Generalised estimating equations were used in logistic regression models of rates of under- and over-interpretation of DCIS by grade.

RESULTS

We evaluated 2097 independent interpretations of DCIS (512 low-grade DCIS and 1585 high-grade DCIS). Agreement with reference diagnoses was 46% (95% confidence interval [CI] 42-51) for low-grade DCIS and 83% (95% CI 81-86) for high-grade DCIS. The proportion of reference low-grade DCIS interpretations over-interpreted by pathologists (i.e. categorised as either high-grade DCIS or invasive cancer) was 23% (95% CI 19-28); 30% (95% CI 26-34) were interpreted as a lower diagnostic category (atypia or benign proliferative). Reference high-grade DCIS was under-interpreted in 14% (95% CI 12-16) of observations and only over-interpreted 3% (95% CI 2-4).

CONCLUSION

Grade is a major factor when examining pathologists' variability in diagnosing DCIS, with much lower agreement for low-grade DCIS cases compared to high-grade. These findings support the hypothesis that low-grade DCIS poses a greater interpretive challenge than high-grade DCIS, which should be considered when developing DCIS management strategies.

摘要

背景

导管原位癌(DCIS)的病理学家诊断一致性为84%。关于根据分级进行解释性差异的研究有限。

方法

115名病理学家的全国样本对乳腺病理研究中的240例乳腺病理检测集病例进行了解读,并将他们的解读与专家共识解读进行了比较。我们评估了病理学家的解读与DCIS的共识参考诊断的一致性,DCIS分为低级别和高级别病变。广义估计方程用于DCIS按分级的低解读率和高解读率的逻辑回归模型。

结果

我们评估了2097例DCIS的独立解读(512例低级别DCIS和1585例高级别DCIS)。低级别DCIS与参考诊断的一致性为46%(95%置信区间[CI]42 - 51),高级别DCIS为83%(95%CI 81 - 86)。病理学家将参考低级别DCIS解读为高级别DCIS或浸润性癌(即过度解读)的比例为23%(95%CI 19 - 28);30%(95%CI 26 - 34)被解读为较低诊断类别(非典型增生或良性增生)。参考高级别DCIS在14%(95%CI 12 - 16)的观察中被低解读,仅3%(95%CI 2 - 4)被过度解读。

结论

分级是检查病理学家诊断DCIS变异性时的一个主要因素,低级别DCIS病例的一致性远低于高级别。这些发现支持了低级别DCIS比高级别DCIS带来更大解释挑战的假设,在制定DCIS管理策略时应予以考虑。

相似文献

1
The diagnostic challenge of low-grade ductal carcinoma in situ.低级别导管原位癌的诊断挑战
Eur J Cancer. 2017 Jul;80:39-47. doi: 10.1016/j.ejca.2017.04.013. Epub 2017 May 20.
8
Low-Grade Ductal Carcinoma In Situ.低级别导管原位癌。
Am J Clin Pathol. 2020 Feb 8;153(3):360-367. doi: 10.1093/ajcp/aqz179.

引用本文的文献

6
Should low-risk DCIS lose the cancer label? An evidence review.低危 DCIS 是否应该去掉“癌症”标签?一项证据回顾。
Breast Cancer Res Treat. 2023 Jun;199(3):415-433. doi: 10.1007/s10549-023-06934-y. Epub 2023 Apr 19.

本文引用的文献

2
Addressing overtreatment of screen detected DCIS; the LORIS trial.解决过度治疗筛查出的 DCIS 问题;LORIS 试验。
Eur J Cancer. 2015 Nov;51(16):2296-303. doi: 10.1016/j.ejca.2015.07.017. Epub 2015 Aug 18.
4
It is overtreatment, not overdiagnosis.这是过度治疗,而非过度诊断。
Acad Radiol. 2015 Aug;22(8):1044-5. doi: 10.1016/j.acra.2015.06.006. Epub 2015 Jun 19.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验